ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Viridian Therapeutics Inc

Viridian Therapeutics Inc (VRDN)

14.98
0.48
(3.31%)
Closed July 22 4:00PM
14.98
0.00
( 0.00% )
Pre Market: 4:07AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
14.98
Bid
13.88
Ask
17.23
Volume
-
0.00 Day's Range 0.00
10.925 52 Week Range 24.18
Market Cap
Previous Close
14.98
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,026,284
Shares Outstanding
63,822,468
Dividend Yield
-
PE Ratio
-4.02
Earnings Per Share (EPS)
-3.72
Revenue
314k
Net Profit
-237.73M

About Viridian Therapeutics Inc

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being de... Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
1970
Viridian Therapeutics Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker VRDN. The last closing price for Viridian Therapeutics was $14.98. Over the last year, Viridian Therapeutics shares have traded in a share price range of $ 10.925 to $ 24.18.

Viridian Therapeutics currently has 63,822,468 shares outstanding. The market capitalization of Viridian Therapeutics is $956.06 million. Viridian Therapeutics has a price to earnings ratio (PE ratio) of -4.02.

VRDN Latest News

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare...

Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease

- On track to initiate two phase 3 clinical trials of VRDN-003 in August 2024 - - REVEAL-1 and REVEAL-2, will evaluate two active dosing regimens of subcutaneously (SC) administered VRDN-003 in...

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare...

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that...

Viridian Therapeutics to Participate in Upcoming May Investor Conferences

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10014.9816.9914.02117303115.30295012CS
41.8313.916349809913.1516.9911.8598301913.70928185CS
121.6612.462462462513.3216.9911.4102628413.25643787CS
26-5.41-26.532614026520.3921.4611.495546715.50799807CS
52-5.43-26.604605585520.4124.1810.92587449016.40024038CS
156-2.51-14.351057747317.49399.4758403919.61215682CS
260-6.41-29.967274427321.39399.4750382819.59323922CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NMHINatures Miracle Holding Inc
$ 0.9691
(176.89%)
5.79M
GPGreenPower Motor Company Inc
$ 1.79
(59.11%)
4
FEIMFrequency Electronics Inc
$ 13.34
(32.08%)
77.65k
LGHLWLion Group Holding Ltd
$ 0.0093
(30.99%)
156
ENGENGlobal Corp
$ 2.22
(29.82%)
258
RNAZTransCode Therapeutics Inc
$ 0.3173
(-59.96%)
284.54k
MIRAMIRA Pharmaceuticals Inc
$ 3.58
(-28.54%)
745.72k
CMAXCareMax Inc
$ 3.95
(-23.89%)
249.49k
NUKKNukkleus Inc
$ 0.3943
(-20.82%)
127.08k
XCURExicure Inc
$ 0.4128
(-17.41%)
5.59k
NMHINatures Miracle Holding Inc
$ 0.9691
(176.89%)
5.79M
LIFWMSP Recovery Inc
$ 0.6221
(22.77%)
2.96M
BREABrera Holdings PLC
$ 0.682
(-7.48%)
1.55M
SLNASelina Hospitality PLC
$ 0.0353
(-4.59%)
1.04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.52
(1.61%)
1M

Your Recent History

Delayed Upgrade Clock